Alzheimer’s disease

5. Drugs and Medications
Anderson, L., Morath, R., & Light, E. (2004). Estimating the dollar utility of changes in job performance due to seasonal Allergic Rhinitis and its treatment. Human Performance, 17(1), 43-69. Gottschalk, L. A., Bechtel, R. J., Maguire, G. A., Harrington, D. E., Levinson, D. M., Franklin, D. L., et al. (2000). Computerized measurement of cognitive impairment and associated neuropsychiatric dimensions. Comprehensive Psychiatry, 41(5), 326-333. Gottschalk, L. A., Bechtel, R. J., Maguire, G. A., Katz, M. L., Levinson, D. M., Harrington, D. E., et al. (2002). Computer detection of cognitive impairment and associated neuropsychiatric dimensions from the content analysis of verbal samples. American Journal of Drug and Alcohol Abuse, 28(4), 653-670. Hamidovic, A., Kang, U. J., & de Wit, H. (2008). Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers. Journal of Clinical Psychopharmacology, 28(1), 45-51. Kane, R. L., Loreck, D., May, C., DiPino, K., & Reeves, D. L. (1996). Metrics for assessing treatment efficacy in dementia: A new perspective regarding speed and accuracy measures [Abstract]. Archives of Clinical Neuropsychology, 11(5), 405-406. Kay, G. G., Berman, B., Mockoviak, S. H., Morris, C. E., Reeves, D. L., Starbuck, V., et al. (1997). Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance. Archives of Internal Medicine, 157, 2350-2356. Lewandowski, A. G., Dietz, A. J., & Reeves, D. L. (1995). A neuropsychologic- pharmacodynamic paradigm for demonstrating cognitive enhancement and suppression in the elderly [Abstract]. Archives of Clinical Neuropsychology, 10(4), 357-358. Lewandowski, A. G., Francom, S., Reeves, D., Spector, J., Cole, J., & Levinson, D. M. (1999). Methodological considerations of high-n testing with neuropsychological measures [Abstract]. Archives of Clinical Neuropsychology, 14(1), 83-84. Lewandowski, A. G., Reeves, D. L., Kane, R., & Spector, J. (2000). A Phase III clinical trial using a comprehensive neuropsychological battery to assess the effects of over-the-counter medication on cognitive functioning in the elderly [Abstract]. Archives of Clinical Neuropsychology, 15(8), 752-753. Lewandowski, A. G., Reeves, D., Spector, J., & Cole, J. (1999). Differential neuropsychological effects of two antidiuretic medications in older adults [Abstract]. Archives of Clinical Neuropsychology, 14(8), 644. Poyurovsky, M., Koren, D., Gonopolsky, I., Schneidman, M., Fuchs, C., Weizman, A., et al. (2003). Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: An add-on, double-blind placebo-controlled study. European Neuropsychopharmacology, 13(2), 123-128. Smith, R. C., Singh, A., Infante, M., Khandat, A., & Kloos, A. (2002). Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology, 27(3), 479-497. White, H. K., & Levin, E. D. (1999). Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology, 143, 158-165. White, H. K., & Levin, E. D. (2004). Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment. Psychopharmacology, 171, 465-471. Wilken, J. A., Kane, R. L., Ellis, A. K., Rafeiro, E., Briscoe, M. P., Sullivan, C. L., et al. (2003). A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis. Annals of Allergy, Asthma and Immunology, 91, 375-385. Wilken, J. A., Sullivan, C. L., Lewandowski, A., & Kane, R. L. (2007). The use of ANAM to assess the side-effect profiles and efficacy of medication. Archives of Clinical Neuropsychology, 22(S1), S127-S133.

Source: http://c-shop.ou.edu/biblio/docs/drugmed.pdf